Pan Dong Ryu

Pan Dong Ryu

Auto-generated profile, based on publicly available information

Pan Dong Ryu

Council on Education, Korean Association of Veterinary Medical Colleges, Seoul 08826, Korea

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SJSoo Hwa Jang
Soo Hwa Jang
SCSeon Young Choi
Seon Young Choi
PRPan Dong Ryu
Pan Dong Ryu
SLSo Yeong Lee
So Yeong Lee

1 June 2011 in Experimental Neurology
Verified
Journal Article
Closed access
CLChoong Hyun Lee
Choong Hyun Lee
JPJoon Ha Park
Joon Ha Park
KYKi-Yeon Yoo
Ki-Yeon Yoo
JCJung Hoon Choi
Jung Hoon Choi
IHIn Koo Hwang
In Koo Hwang
MWMoo-Ho Won
Moo-Ho Won

1 July 2015 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
SLSo Yeong Lee
So Yeong Lee
SCSeon Young Choi
Seon Young Choi
MSMin Seok Song
Min Seok Song
PRPan Dong Ryu
Pan Dong Ryu
SJSang-Woo Joo
Sang-Woo Joo
ALAnh Thu Ngoc Lam
Anh Thu Ngoc Lam
Gold nanoparticles (AuNPs) are attractive materials for use in biomedicine due to their physical properties. Increasing evidence suggests that several nanoparticles induce the differentiation of human mesenchymal stem cells into osteoblasts and adipocytes. In this study, we hypothesized that chitosan-conjugated AuNPs promote the osteogenic differentiation of human adipose-derived mesenchymal stem cells. For the evaluation of osteogenic differentiation, alizarin red staining, an alamarBlue® assay, and a quantitative real-time polymerase chain reaction analysis were performed. In order to examine specific signaling pathways, immunofluorescence and a western blotting assay were performed. Our results demonstrate that chitosan-conjugated AuNPs increase the deposition of calcium content and the expression of marker genes related to osteogenic differentiation in human adipose-derived mesenchymal stem cells at nontoxic concentrations. These results indicate that chitosan-conjugated AuNPs promote osteogenesis through the Wnt/β-catenin signaling pathway. Therefore, chitosan-conjugated AuNPs can be used as a reagent for promoting bone formation.

1 August 2011 in Cell Transplantation
Verified
Journal Article
Closed access
YSYoojin Seo
Yoojin Seo
SYSe-Ran Yang
Se-Ran Yang
MJMin Ki Jee
Min Ki Jee
EJEun Kyung Joo
Eun Kyung Joo
KRKyung-Hwan Roh
Kyung-Hwan Roh
KKKyung-Sun Kang
Kyung-Sun Kang
Niemann Pick disease type C1 (NPC) is an autosomal recessive disease characterized by progressive neurological deterioration leading to premature death. In this study, we hypothesized that human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) have the multifunctional abilities to ameliorate NPC symptoms in the brain. To test this hypothesis, hUCB-MSCs were transplanted into the hippocampus of NPC mice in the early asymptomatic stage. This transplantation resulted in the recovery of motor function in the Rota Rod test and impaired cholesterol homeostasis leading to increased levels of cholesterol efflux-related genes such as LXRα, ABCA1, and ABCG5 while decreased levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase were observed in NPC mice. In the cerebrum, hUCB-MSCs enhanced neuronal cell survival and proliferation, where they directly differentiated into electrically active MAP2-positive neurons as demonstrated by whole-cell patch clamping. In addition, we observed that hUCB-MSCs reduced Purkinje neuronal loss by suppression of inflammatory and apoptotic signaling in the cerebellum as shown by immunohistochemistry. We further investigated how hUCB-MSCs enhance cellular survival and inhibit apoptosis in NPC mice. Neuronal cell survival was associated with increased PI3K/AKT and JAK2/STAT3 signaling; moreover, hUCB-MSCs modulated the levels of GABA/glutamate transporters such as GAT1, EAAT2, EAAT3, and GAD6 in NPC mice as assessed by Western blot analysis. Taken together, our findings suggest that hUCB-MSCs might play multifunctional roles in neuronal cell survival and ameliorating motor deficits of NPC mice.

1 May 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SJSoo Hwa Jang
Soo Hwa Jang
JBJun Kyu Byun
Jun Kyu Byun
WJWon-Il Jeon
Won-Il Jeon
SCSeon Young Choi
Seon Young Choi
JPJin Park
Jin Park
SLSo Yeong Lee
So Yeong Lee
It is widely known that ion channels are expressed in the plasma membrane. However, a few studies have suggested that several ion channels including voltage-gated K+ (Kv) channels also exist in intracellular organelles where they are involved in the biochemical events associated with cell signaling. In the present study, western blot analysis using fractionated protein clearly indicates that Kv1.3 channels are expressed in the nuclei of MCF7, A549, SNU-484 cancer cells, and human brain tissues. In addition, Kv1.3 is located in the plasma membrane and the nucleus of Jurkat T cells. Nuclear membrane hyperpolarization after treatment with margatoxin (MgTX), a specific blocker of Kv1.3 channels, provides evidence for functional channels at the nuclear membrane of A549 cells. MgTX-induced hyperpolarization is abolished in the nuclei of Kv1.3 silenced cells, and the effects of MgTX are dependent on the magnitude of the K+ gradient across the nuclear membrane. Selective Kv1.3 blockers induce the phosphorylation of cAMP response element-binding (CREB) and c-Fos activation. Moreover, Kv1.3 is shown to form a complex with the upstream binding factor 1 in the nucleus. Chromatin immunoprecipitation assay reveals that Sp1 transcription factor is directly bound to the promoter region of the Kv1.3 gene, and the Sp1 regulates Kv1.3 expression in the nucleus of A549 cells. These results demonstrate that Kv1.3 channels are primarily localized in the nucleus of several types of cancer cells and human brain tissues where they are capable of regulating nuclear membrane potential and activation of transcription factors, such as pCREB and c-Fos.

1 July 2010 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
PDF file
THTae Hee Han
Tae Hee Han
KLKiho Lee
Kiho Lee
JPJin Bong Park
Jin Bong Park
DADongchoon Ahn
Dongchoon Ahn
JPJae-Hyeong Park
Jae-Hyeong Park
PRPan Dong Ryu
Pan Dong Ryu
Neuronal activity in the paraventricular nucleus (PVN) is known to be elevated in rats with heart failure. However, the type of neurons involved and the underlying synaptic mechanisms remain unknown. Here we examined spontaneous firing activity and synaptic currents in presympathetic PVN neurons in rats with myocardial infarction (MI), using slice patch clamp combined with the retrograde labeling technique. In PVN neurons projecting to the rostral ventrolateral medulla (PVN-RVLM), MI induced a significant increase in basal firing rate (1.79 to 3.02 Hz, P < 0.05) and a reduction in the frequency of spontaneous ( P < 0.05) and miniature ( P < 0.01) inhibitory postsynaptic currents (IPSCs). In addition, MI induced an increase in the paired-pulse ratio of evoked IPSCs ( P < 0.05). Bicuculline, a GABAA receptor antagonist, increased the firing rate of PVN-RVLM neurons in sham-operated (1.21 to 2.74 Hz, P < 0.05) but not MI ( P > 0.05) rats. In contrast, in PVN neurons projecting to the intermediolateral horn of the spinal cord (PVN-IML), MI did not induce any significant changes in the basal firing rate and the properties of spontaneous and miniature IPSCs. The properties of spontaneous excitatory postsynaptic currents (EPSCs) were not altered in either neuron group. In conclusion, our results indicate that MI induces an elevation of firing activity in PVN-RVLM but not in PVN-IML neurons and that the elevated firing rate is largely due to a decrease in GABA release. These results provide evidence for a novel target-selective synaptic plasticity in the PVN that is associated with the sympathetic hyperactivity commonly seen in heart failure.